Director at Varex Imaging (VREX) awarded 12,331 deferred stock units

Rhea-AI Filing Summary

Varex Imaging Corp director Christine A. Tsingos received an equity grant of 12,331 deferred stock units on February 12, 2026. The units were awarded at a price of $0 and are held directly. Each deferred stock unit converts into one share of Varex common stock.

The deferred stock units vest 100% on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders after the grant. Vested shares will be delivered to the director on the earlier of the third anniversary of the grant date, a change in control, or her termination of service.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider TSINGOS CHRISTINE A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	12,331	$0.00	--

Holdings After Transaction: Deferred Stock Units — 12,331 shares (Direct)

Footnotes (1)

1. Each Deferred Stock Unit converts into common stock on a one-for-one basis. These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TSINGOS CHRISTINE A

(Last) (First) (Middle)

C/O VAREX IMAGING CORP

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UT 84104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/12/2026		A		12,331		(2)	(2)	Common Stock	12,331	$0	12,331	D

Explanation of Responses:

1. Each Deferred Stock Unit converts into common stock on a one-for-one basis.

2. These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Remarks:

	/s/ Christine A. Tsingos	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Varex Imaging Corp (VREX) report for Christine A. Tsingos?

Varex Imaging Corp reported that director Christine A. Tsingos received a grant of 12,331 deferred stock units. The award was made on February 12, 2026, at a price of $0 per unit and is held as a direct ownership position.

How many deferred stock units were granted to the VREX director?

The director received 12,331 deferred stock units. These units are derivative securities that each convert into one share of Varex common stock, giving the grant a potential future value tied directly to the company’s share price performance.

When do Christine A. Tsingos’s deferred stock units at Varex (VREX) vest?

The deferred stock units vest 100% on the earlier of the one-year anniversary of the February 12, 2026 grant date or the next annual meeting of stockholders. This schedule links vesting to either time-based service or the company’s regular governance cycle.

When will the VREX director receive shares from the deferred stock units?

Shares from the deferred stock units will be delivered on the earlier of the third anniversary of the grant date, a change in control, or the director’s termination of service. This structure delays actual share delivery while aligning with key career or corporate events.

What does each deferred stock unit represent for Varex Imaging Corp (VREX)?

Each deferred stock unit represents the right to receive one share of Varex common stock. The units do not convert immediately; instead, they vest and are settled in shares based on the specified timing and event conditions described in the award terms.

Is the VREX director’s deferred stock unit grant a purchase or a grant?

The transaction is a grant or award, not a market purchase. The Form 4 uses transaction code “A,” indicating an acquisition through grant or award at a price of $0, typical of equity compensation for directors rather than an open-market investment.